187 related articles for article (PubMed ID: 36358686)
21. Treatment outcomes of mucosal melanoma of head and neck: Efficacy of immune checkpoint inhibitors for advanced disease.
Ohshima S; Ueki Y; Yokoyama Y; Takahashi T; Shodo R; Yamazaki K; Okabe R; Matsuyama H; Togashi T; Takatsuka S; Takenouchi T; Horii A
Front Surg; 2022; 9():1032626. PubMed ID: 37082097
[TBL] [Abstract][Full Text] [Related]
22. Incidence, predictors and 6-month overall outcome of acute kidney injury in Chinese patients receiving PD-1 inhibitors.
Qin Z; Liu K; Xu X; Li T; Ge Y; Wu B; Xing C; Mao H
Future Oncol; 2022 May; 18(16):1951-1962. PubMed ID: 35232231
[TBL] [Abstract][Full Text] [Related]
23. Azithromycin-Induced, Biopsy-Proven Acute Interstitial Nephritis in an Adult Successfully Treated with Low-Dose Corticosteroids.
Woodruff AE; Meaney CJ; Hansen EA; Prescott GM
Pharmacotherapy; 2015 Nov; 35(11):e169-74. PubMed ID: 26598102
[TBL] [Abstract][Full Text] [Related]
24. Immune-Related Adverse Events by Immune Checkpoint Inhibitors Significantly Predict Durable Efficacy Even in Responders with Advanced Non-Small Cell Lung Cancer.
Akamatsu H; Murakami E; Oyanagi J; Shibaki R; Kaki T; Takase E; Tanaka M; Harutani Y; Yamagata N; Okuda Y; Furuta K; Sugimoto T; Teraoka S; Hayata A; Tokudome N; Ozawa Y; Mori K; Koh Y; Yamamoto N
Oncologist; 2020 Apr; 25(4):e679-e683. PubMed ID: 32297443
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness of immune checkpoint inhibitors in combination with stereotactic radiosurgery for patients with brain metastases from renal cell carcinoma: inverse probability of treatment weighting using propensity scores.
Yomo S; Oda K; Oguchi K
J Neurosurg; 2023 Jun; 138(6):1591-1599. PubMed ID: 36308485
[TBL] [Abstract][Full Text] [Related]
26. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013257. PubMed ID: 33316104
[TBL] [Abstract][Full Text] [Related]
27. Acute Kidney Injury Induced by Immune Checkpoint Inhibitors.
Tian R; Liang J; Li R; Zhou X
Kidney Dis (Basel); 2022 May; 8(3):190-201. PubMed ID: 35702709
[TBL] [Abstract][Full Text] [Related]
28. Cytokines and Immune Cell Phenotype in Acute Kidney Injury Associated With Immune Checkpoint Inhibitors.
Farooqui N; Zaidi M; Vaughan L; McKee TD; Ahsan E; Pavelko KD; Villasboas JC; Markovic S; Taner T; Leung N; Dong H; Alexander MP; Herrmann SM
Kidney Int Rep; 2023 Mar; 8(3):628-641. PubMed ID: 36938084
[TBL] [Abstract][Full Text] [Related]
29. Biopsy-proven acute interstitial nephritis, 1993-2011: a case series.
Muriithi AK; Leung N; Valeri AM; Cornell LD; Sethi S; Fidler ME; Nasr SH
Am J Kidney Dis; 2014 Oct; 64(4):558-66. PubMed ID: 24927897
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathological Features of Kidney Injury Related to Immune Checkpoint Inhibitors: A Systematic Review.
Xu LY; Zhao HY; Yu XJ; Wang JW; Zheng XZ; Jiang L; Wang SX; Liu G; Yang L
J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36835884
[TBL] [Abstract][Full Text] [Related]
31. Predicting survival of NSCLC patients treated with immune checkpoint inhibitors: Impact and timing of immune-related adverse events and prior tyrosine kinase inhibitor therapy.
Sayer MR; Mambetsariev I; Lu KH; Wong CW; Duche A; Beuttler R; Fricke J; Pharoan R; Arvanitis L; Eftekhari Z; Amini A; Koczywas M; Massarelli E; Roosan MR; Salgia R
Front Oncol; 2023; 13():1064169. PubMed ID: 36860308
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of immune checkpoint inhibitors with or without radiotherapy in metastatic non-small cell lung cancer: A systematic review and meta-analysis.
Liu Z; Xu T; Chang P; Fu W; Wei J; Xia C; Wang Q; Li M; Pu X; Huang F; Ge C; Gao Y; Gong S; Liu C; Dong L
Front Pharmacol; 2023; 14():1064227. PubMed ID: 36762107
[No Abstract] [Full Text] [Related]
33. Long-term Renal Outcome of Biopsy-proven Acute Tubular Necrosis and Acute Interstitial Nephritis.
Kim H; Jo SK; Ahn SY; Kwon YJ; Lee H; Oh J; Chin HJ; Lim K; Lee J; Yang J; Kim MG; Cho WY; Oh SW
J Korean Med Sci; 2020 Jul; 35(26):e206. PubMed ID: 32627439
[TBL] [Abstract][Full Text] [Related]
34. Immune-Related Adverse Events as Clinical Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
Martini DJ; Goyal S; Liu Y; Evans ST; Olsen TA; Case K; Magod BL; Brown JT; Yantorni L; Russler GA; Caulfield S; Goldman JM; Nazha B; Harris WB; Kissick HT; Master VA; Kucuk O; Carthon BC; Bilen MA
Oncologist; 2021 Oct; 26(10):e1742-e1750. PubMed ID: 34156726
[TBL] [Abstract][Full Text] [Related]
35. Immunotherapy and the Spectrum of Kidney Disease: Should We Individualize the Treatment?
Bermejo S; Bolufer M; Riveiro-Barciela M; Soler MJ
Front Med (Lausanne); 2022; 9():906565. PubMed ID: 35775000
[TBL] [Abstract][Full Text] [Related]
36. Immune checkpoint inhibitors in patients with chronic kidney disease: Assessing their ability to cause acute kidney injury and informing their proper use.
Min JW; Lim JU
Semin Oncol; 2022 Apr; 49(2):141-147. PubMed ID: 35264308
[TBL] [Abstract][Full Text] [Related]
37. Case Report: Successful treatment of late-onset immune checkpoint inhibitor-associated membranous nephropathy in a patient with advanced renal cell carcinoma.
Ratanasrimetha P; Reddy VD; Kala J; Tchakarov A; Glass WF; Msaouel P; Lin JS
Front Immunol; 2022; 13():898811. PubMed ID: 35967405
[TBL] [Abstract][Full Text] [Related]
38. Diagnosis and management of immune checkpoint inhibitor-associated acute kidney injury.
Sprangers B; Leaf DE; Porta C; Soler MJ; Perazella MA
Nat Rev Nephrol; 2022 Dec; 18(12):794-805. PubMed ID: 36168055
[TBL] [Abstract][Full Text] [Related]
39. Incidence, predictors, and survival impact of acute kidney injury in patients with melanoma treated with immune checkpoint inhibitors: a 10-year single-institution analysis.
Abdelrahim M; Mamlouk O; Lin H; Lin J; Page V; Abdel-Wahab N; Swan J; Selamet U; Yee C; Diab A; Suki W; Abudayyeh A
Oncoimmunology; 2021 May; 10(1):1927313. PubMed ID: 34104543
[No Abstract] [Full Text] [Related]
40. Acute tubulointerstitial nephritis induced by checkpoint inhibitors versus classical acute tubulointerstitial nephritis: are they the same disease?
Draibe JB; García-Carro C; Martinez-Valenzuela L; Agraz I; Fulladosa X; Bolufer M; Tango A; Torras J; Soler MJ
Clin Kidney J; 2021 Mar; 14(3):884-890. PubMed ID: 33777371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
